Variable | Total patients | Percentage |
---|---|---|
Total patients | 200 | 100 |
Male | 151 | 75.5 |
Female | 49 | 24.5 |
Median age at diagnosis | 200 | 22 yrs. (4–79 years) |
  < 14 years | 40 | 20 |
  > 14–21 | 57 | 28.5 |
  > 21–30 | 39 | 19.5 |
  > 30–50 | 50 | 25 |
  > 50 | 14 | 7 |
Stage I | 75 | 37.5 |
Stage II | 70 | 35 |
Stage III | 41 | 20.5 |
Stage IV | 14 | 7 |
Bulky disease involvement | 19 | 9.5 |
Spleen involvement | 22 | 11 |
Extranodal involvement | 25 | 12.5 |
Bone marrow involvement | 5 | 2.5 |
B symptoms present | 14 | 7 |
Early favorablea | 96 | 48 |
Early unfavorablea | 14 | 7 |
Advanceda | 55 | 27.5 |
Risk group unknowna | 35 | 17.5 |
LDH > normal | 40 | 20 |
LDH missing | 50 | 25 |
Performance status > 2 | 6 | 3 |
Performance status unknown | 44 | 22 |